INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on August 28, 2026. The filing primarily discloses a Regulation FD investor presentation intended for the H.C. Wainwright 28th Annual Global Investment Conference (September 14-16, 2026) and provides an update on a previously announced equity financing agreement.
Key Financial Metrics and Capital Activity
The filing does not contain audited financial statements, revenue, profit, or cash flow data for a specific reporting period. However, it details recent capital raising activity under an Any Market Purchase Agreement with Alumni Capital LP:
- Total Commitment: Up to $15 million (expandable to $50 million by mutual agreement).
- Shares Sold to Date: 2,094,395 shares of Common Stock.
- Proceeds Raised: Approximately $3,591,000.
- Average Price Per Share: Approximately $1.71.
Material Changes and Events
The primary material event reported is the execution of share sales under the Purchase Agreement entered into on July 24, 2026. The Company has utilized the agreement to raise capital since the registration statement became effective. No other material changes to operations or financial condition are detailed in this specific filing text.
Guidance, Outlook, and Risks
The Company is furnishing an investor presentation (Exhibit 99.1) that addresses current operations, performance, and industry conditions. The filing explicitly states that the presentation contains forward-looking statements subject to risks and uncertainties. The Company undertakes no obligation to update or amend the materials furnished. The filing does not provide specific numerical guidance or detailed risk factors within the text of the 8-K itself, referring instead to the attached presentation.
Key Facts for Investor Verification
- Verify the full content of the investor presentation (Exhibit 99.1) for detailed operational metrics and forward-looking guidance.
- Confirm the remaining capacity under the $15 million Purchase Agreement with Alumni Capital LP.
- Review the Company's website (www.invofertility.com) for the posted presentation materials.
- Note that the information in the attached presentation is not deemed "filed" under Section 18 of the Exchange Act.